This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Korea Institute of Science and Technology. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Ki Sung Kang: Innovator in Insulin Secretion
Introduction
Ki Sung Kang is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of medical science, particularly in the area of insulin secretion.
Latest Patents
Ki Sung Kang holds a patent for a composition aimed at stimulating insulin secretion from cells. This innovative composition includes an extract or an active ingredient that effectively promotes insulin secretion, providing a potential method for managing diabetes.
Career Highlights
Kang is affiliated with the Korea Institute of Science and Technology, where he conducts research and develops new technologies. His work focuses on enhancing the understanding of insulin secretion mechanisms and finding solutions to related health issues.
Collaborations
Some of his notable coworkers include Jungyeob Ham and Bong Chul Chung, who contribute to the research and development efforts at the institute.
Conclusion
Ki Sung Kang's work in developing a composition for stimulating insulin secretion showcases his commitment to advancing medical science. His contributions are vital in the ongoing efforts to improve diabetes management and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile